Asian healthcare-focused private equity firm Quadria Capital said on Tuesday it has secured total commitments of $1.07 billion for its third fund, surpassing an original target of $800 million.

Aragen has announced the appointment of Manjunath Ramarao as Chief Scientific Officer (CSO) and Executive Vice President of Integrated Drug Discovery. Ramarao has more than 25 years of experience in ...

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by a confluence of factors, including cost advantages, technological ...

10th March, 2025, Hyderabad: Aragen, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced two senior level appointments. Dr. Manjunath Ramarao has been ...

NCP to finalise charter, organogram soon Some of the top leaders of the party stand on stage as the rally for launching National Citizen Party comes to a close yesterday. Photo:Star ...

Pharma Sector Multibagger Opportunity - Explore how India could win big in the CDMO space with China-Plus-One strategy, growing investments, strategic advantages, and the Pharma sector's global shift.

Aragen Life Sciences hauled in a $100 million investment from private equity firm Quadria Capital that the India-based CDMO plans to use to expand its infrastructure and global operations.

Hyderabad: Contract research, development, and manufacturing organisation (CRDMO) Aragen Life Science, formerly known as GVK Biosciences, secured a $100 million (approx. 865 crore) investment from ...

Aragen Life Science secures $100 million investment from Quadria Capital to expand capabilities and meet growing outsourcing demand.

Aragen Life Sciences, a global Contract Research, Development, and Manufacturing Organisation (CRDMO), has secured $100 million investment from Quadria Capital, an Asia-focussed healthcare private ...

Aragen Life Science, formerly GVK Biosciences, secures a $100 million investment from healthcare-focused private equity fund Quadria Capital.